BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2161198)

  • 1. Teniposide (VM26) as second-line treatment for small cell lung cancer.
    Tummarello D; Guidi F; Torresi U; Dazzi C; Cellerino R
    Anticancer Res; 1990; 10(2A):397-9. PubMed ID: 2161198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing response to second-line treatment with teniposide (VM26) in patients with progressive small cell lung cancer (SCLC).
    Tummarello D; Graziano F; Giordani P; Cellerino R
    Anticancer Res; 1993; 13(4):1055-8. PubMed ID: 8394668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study with teniposide (VM26) in patients with progressed or relapsed small cell lung cancer (SCLC).
    Tummarello D; Guidi F; Di Furia L; Gramazio A; Menichetti E; Cellerino R
    J Chemother; 1989 Feb; 1(1):64-7. PubMed ID: 2542470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of teniposide in small cell carcinoma of the lung.
    Pedersen AG; Bork E; Osterlind K; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1984 Oct; 68(10):1289-91. PubMed ID: 6098366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
    Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
    Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy.
    Giaccone G; Donadio M; Bonardi G; Testore F; Calciati A
    J Clin Oncol; 1988 Aug; 6(8):1264-70. PubMed ID: 2842464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teniposide in the treatment of non-small cell lung carcinoma.
    Giaccone G; Donadio M; Ferrati P; Bonardi G; Ciuffreda L; Bagatella M; Calciati A
    Cancer Treat Rep; 1987 Jan; 71(1):83-5. PubMed ID: 3024829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology Group.
    Grozea PN; Crowley JJ; Canfield VA; Kingsbury L; Ross SW; Beltran GS; Laufman LR; Weiss GR; Livingston RB
    Cancer; 1997 Sep; 80(6):1029-33. PubMed ID: 9305702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teniposide (VM26): an effective treatment for brain metastases of small cell carcinoma of the lung.
    Giaccone G; Donadio M; Bonardi GM; Testore F; Calciati A
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):629-31. PubMed ID: 2838291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer.
    Leighl NB; Goss GD; Lopez PG; Burkes RL; Dancey JE; Rahim YH; Rudinskas LC; Pouliot JF; Rodgers A; Pond GR; Shepherd FA
    Lung Cancer; 2006 Jun; 52(3):327-32. PubMed ID: 16597474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of second-line bendamustine chemotherapy in relapsed small cell lung cancer patients.
    Schmittel A; Knödler M; Hortig P; Schulze K; Thiel E; Keilholz U
    Lung Cancer; 2007 Jan; 55(1):109-13. PubMed ID: 17097191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer.
    Ardizzoni A; Manegold C; Debruyne C; Gaafar R; Buchholz E; Smit EF; Lianes P; ten Velde G; Bosquee L; Legrand C; Neumaier C; King K;
    Clin Cancer Res; 2003 Jan; 9(1):143-50. PubMed ID: 12538462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301.
    Onoda S; Masuda N; Seto T; Eguchi K; Takiguchi Y; Isobe H; Okamoto H; Ogura T; Yokoyama A; Seki N; Asaka-Amano Y; Harada M; Tagawa A; Kunikane H; Yokoba M; Uematsu K; Kuriyama T; Kuroiwa Y; Watanabe K;
    J Clin Oncol; 2006 Dec; 24(34):5448-53. PubMed ID: 17135647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy of small-cell lung cancer by a combination of teniposide, ifosfamide and carboplatin].
    Moro D; Orfeuvre H; Nagy-Mignotte H; Mousseau M; Blanc-Jouvan F; Schaerer R; Brambilla C
    Bull Cancer; 1994 Jan; 81(1):38-42. PubMed ID: 7949582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antitumor activity of teniposide against carcinoma of the lung in human tumor clonogenic assay.
    Matsushima Y; Kanzawa F; Miyazawa N; Sasaki Y; Saijo N
    Anticancer Res; 1986; 6(5):921-4. PubMed ID: 3026235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Teniposide and cisplatin compared with etoposide and cisplatin for treatment of small cell lung cancer].
    Fan Y; Huang ZY; Zhang YP; Sun L
    Ai Zheng; 2002 Dec; 21(12):1368-71. PubMed ID: 12520751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
    Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teniposide in the treatment of small cell lung cancer: a review.
    Hansen HH; Dombernowsky P; Hansen M; Bork E
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):65-8. PubMed ID: 1329227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination versus alternating chemotherapy in small-cell lung cancer.
    Lai SL; Perng RP
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jul; 63(7):513-20. PubMed ID: 10934803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.